To compare two rectum separation methods during intracavitary brachytherapy treatment in cervical cancer
Not Applicable
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2023/02/050059
- Lead Sponsor
- Principal IGMC Shimla
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Karnofsky status >70
normal biochemistry and biochemical profile
IB to IV A stage
no previous treatment
Exclusion Criteria
stage IA and IVA
previously treated cases
unfit for brachytherapy
Karnofsky status <70
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the ICRU rectum point doses in RR alone and RR+ ROVP in patients of histopathological proven cervical cancer receiving intracavitary brachytherapy with tandem ring applicators. <br/ ><br>Timepoint: 2 year
- Secondary Outcome Measures
Name Time Method To compare the ICRU bladder point doses and dose volume parametersTimepoint: one year